The Yonglin Healthcare Foundation is to partner with BioNTech to develop mRNA-based cancer immunotherapies, said Terry Gou (郭台銘), founder of the foundation and manufacturing giant Hon Hai Precision Industry.
BioNTech is also planning to set up a clinical trial hub in Taiwan for mRNA-based cancer immunotherapies as part of its Asia-Pacific expansion, Gou wrote on Facebook on Friday.
The German biotech firm, which developed a widely used mRNA COVID-19 vaccine, said in a separate statement that it would collaborate with Yonglin after signing a memorandum of understanding with Retain Biotech Corp.
Retain Biotech, a Taiwan-based company sponsored by the foundation, is engaged in precision and genomic medicine and cell therapy for treating cancers, BioNTech said.
Gou said the German company has set up an office in Taiwan to perform an initial assessment of its cancer product candidate, BNT113, which is targeted at treating head and neck cancers.
Taiwan is expected to participate in BioNTech’s mRNA-based cancer immunotherapy development, he said.
BioNTech said that BNT113 is expected to be the first of several novel cancer immunotherapies that it anticipates assessing in the region.
Under the memorandum of understanding, Retain is expected to support the clinical evaluation of BNT113 in a randomized phase two clinical trial across the region, BioNTech said.
“BioNTech’s mRNA technology has not only saved the world from the COVID-19 pandemic, but also raised hopes that the technology will help medical circles take a leap in cancer treatment,” Gou said.
“That has been the intention of BioNTech founder and CEO Ugur Sahin, and it is the first time that he believes his wish to beat cancer could come true,” he said.
At Gou’s invitation, BioNTech executives in January visited the National Taiwan University Cancer Center to better understand Taiwan’s cancer treatment environment, its medical equipment and achievements in the biotech field.
While in Taiwan, the executives evaluated Taiwan’s needs in the hopes of creating a blueprint for treating cancer in the country, Gou said.
In July, he led a delegation to BioNTech’s headquarters in Germany to brief Sabin on Taiwan’s plans to work with the company on head and neck cancer, breast cancer and leukemia.
In the Facebook post, Gou praised the partnership, saying that Taiwan could not afford to be left behind in the battle against cancer.
BioNTech chief business officer Sean Marett said his company’s goal with the Retain agreement was to accelerate the development of innovative therapies to help address cancers, which have been highly prevalent in the region.
BioNTech said it planned to evaluate BNT113 in the broader Asia-Pacific region starting with clinical trials in Taiwan and in Australia’s Victoria state.
It will also assess the expansion of clinical activities to Japan, South Korea, Singapore and other economies in the region for cancer-related therapies, which already encompasses 18 product candidates in 23 ongoing clinical trials.
Chinese President Xi Jinping (習近平) is aware that Beijing’s treatment of Hong Kong has weakened any possible sentiment for a “one country, two systems” arrangement for Taiwan, and has instructed Chinese Communist Party (CCP) politburo member Wang Huning (王滬寧) to develop new ways of defining cross-strait relations, Japanese news magazine Nikkei Asia reported on Thursday. A former professor of international politics at Fu Dan University, Wang is expected to develop a dialogue that could serve as the foundation for cross-strait unification, and Xi plans to use the framework to support a fourth term as president, Nikkei Asia quoted an anonymous source
LUCKY DATE: The man picked the 10th ‘Super Red Envelope’ in a lottery store in Taoyuan’s Jhongli because he broke up with his girlfriend on Jan. 10 A man who recently broke up with his girlfriend won a NT$1 million (US$32,929) prize in the “NT$20 million Super Red Envelope” lottery after picking a card based on the date of their breakup, Taiwan Lottery Co said yesterday. The man, in his 20s, bought the 10th ticket at a lottery store in Taoyuan’s Jhongli District (中壢), because he broke up with his girlfriend on Jan. 10, the store owner told the lottery company. The “Super Red Envelope” lottery was a limited offering by the company during the Lunar New Year holiday, which ended yesterday. The cards, which cost NT$2,000 each, came with
TOURISM BOOST: The transportation system could help attract more visitors to the area, as the line is to connect multiple cultural sites, a city councilor said Residents in New Taipei City’s Ankeng District (安坑) said the local light rail system might have a positive influence, but raised questions about its practicality. The Ankeng light rail system, which is to commence operations after the Lunar New Year holiday, would cut travel time for commuters from Ankeng to downtown Taipei or New Taipei City by 15 to 20 minutes, the city government said. According to the initial plan, there would be one train every 15 minutes during peak time and additional interval trains would run between the densely populated Ankang Station (安康) and Shisizhang Station (十 四張). To encourage people to
CHAMPION TREES: The team used light detection and ranging imaging to locate the tree, and found that it measured a height of 84.1m and had a girth of 8.5m A team committed to finding the tallest trees in the nation yesterday said that an 84.1m tall Taiwania cryptomerioides tree had been named the tallest tree in Taiwan and East Asia. The Taiwan Champion Trees, a team consisting of researchers from the Council of Agriculture’s Taiwan Forestry Research Institute and National Cheng Kung University (NCKU), in June last year used light detection and ranging (LiDAR) imaging to find the giant tree, numbered 55214, upstream of the Daan River (大安溪). A 20-member expedition team led by Rebecca Hsu (徐嘉君), an assistant researcher at the Taiwan Forestry Research Institute, set out to find the